Inovio Pharmaceuticals Stock News

Moderna and AstraZeneca both are making rapid progress on their coronavirus vaccines. For Inovio, this means that the clock is ticking down.

Shares of companies with COVID-19 vaccine candidates were mixed in volatile trading Monday, after the promising results from trials of vaccine candidates...

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Hold rating on Inovio Pharmaceuticals (INO – Research

Shares of companies with COVID-19 vaccine candidates were mixed in volatile trading Monday, after the promising results from trials of vaccine candidates from Pfizer Inc.

Some momentum stocks, like Tesla, have yet to record a full-year profit, but their future potential and recent stock performance have still attracted hordes of buyers.

So far Sunday, July 19, NASDAQ is down -1.01% and the S&P is down -0.16%. Let’s take a look at

Leaders and laggards in the COVID-19 vaccine race -- and how likely they are to win approval.

So far Saturday, July 18, NASDAQ is down -1.01% and the S&P is down -0.16%. Let’s take a look at

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday

A coronavirus vaccine has the potential to not only save countless lives, but also to mitigate trillions in economic damage.

America's highest-profile medical professional waxes optimistic on the potential for a "safe and effective" vaccine by 2021.

U.S. stocks were wavering Friday in the face of slumping U.S. consumer sentiment and escalating rates of coronavirus infections. Consumer sentiment last month missed economists' forecasts, falling to

Investors need a bevy of high-growth stocks as part of every well-rounded biotech portfolio, and the market's furor surrounding the prospect of a COVID-19 vaccine creates the perfect conditions for th

Debt-free and in the limelight, strong fundamentals mean these companies have ample financial headroom for aggressive growth. The post 4 Debt-Free Companies With Strong Stocks to Buy appeared first o

It's a great time to be a small biotech focused on fighting COVID-19. Inovio Pharmaceuticals (NASDAQ: INO) stock has skyrocketed more than 600% higher so far this year. Shares of Sorrento Therape